Evidence map›Paper›PMID 10704159›Full record

ArticleCirculation2000

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

J A Suwaidi, S Hamasaki, S T Higano, R A Nishimura, D R Holmes, A Lerman

9 registry-linked trialsOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 9 registered trials, which are not on this map. Cited by 533 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
533citing papers in PubMed, 4 pooled it
62.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04338165 phase2unknown statusstarted 2021, after this paper: background citation

Effect of Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography : a Monocentric, Prospective, Randomized and Open-label Phase II Trial

Ran2021Enrolled66Registered outcomes6Posted comparisons0ConditionsAtherosclerotic Cardiovascular DiseaseArmsEvolocumab 140 MG/ML [Repatha]
Open the trial in the graph
NCT00666172 phase2completednot on this mapstarted 2008, after this paper: background citation

Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women

TypeinterventionalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2008 to 2012Enrolled270ConditionsAtherosclerosis, Diabetes Mellitus, Obesity, DyslipidemiaArmsExercise, Weight Loss
NCT00738049 phase2completednot on this mapstarted 2009, after this paper: background citation

A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan

TypeinterventionalSponsorK.Lance GouldRan2009 to 2011Enrolled40ConditionsCoronary Artery Disease, Endothelial DysfunctionArmsdarusentan 100 mg
NCT01337947 completednot on this mapstarted 2011, after this paper: background citation

The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes

TypeobservationalSponsorUniversity of VirginiaRan2011 to 2013Enrolled32ConditionsType 1 DiabetesArmsDefinity microbubbles
NCT01398943 nacompletednot on this mapstarted 2010, after this paper: background citation

Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach

TypeinterventionalSponsorAugusta UniversityRan2010 to 2015Enrolled60ConditionsPulmonary Disease, Chronic ObstructiveArmsTetrahydrobiopterin (BH4), Antioxidant Cocktail
NCT02593344 nacompletednot on this mapstarted 2012, after this paper: background citation

Peripheral Endothelial Function in Asthmatic Patients

TypeinterventionalSponsorHopital FochRan2012 to 2015Enrolled113ConditionsEndothelial FunctionArmsEndopat
NCT02593357 nacompletednot on this mapstarted 2012, after this paper: background citation

Assessment of a Peripheral Endothelial Dysfunction in COPD (Chronic Obstructive Pulmonary Disease)

TypeinterventionalSponsorHopital FochRan2012 to 2017Enrolled137ConditionsChronic Obstructive Pulmonary DiseaseArmsCOPD patients
NCT03149471 unknown statusnot on this mapstarted 2017, after this paper: background citation

The Role of Endothelial Function Test in Risk Stratification for Early and Late Complications After Pulmonary Embolism

TypeobservationalSponsorSheba Medical CenterRan2017 to 2020Enrolled200ConditionsPulmonary DiseaseArmsEndothelial dysfunction test
NCT06176391 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Spinal Cord Stimulation for Vasospastic Angina Pectoris - a Prospective Study

TypeinterventionalSponsorAmsterdam UMC, location VUmcRan2024 to 2024Enrolled10ConditionsAngina Pectoris, AngiospasticArmsSpinal Cord Stimulation
3 · Its place in the literature

Who cites it

533 citing papers in PubMed, 4 syntheses or guidelines pooled it, 2,046 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cardiovascular Changes in Menopause.Current cardiology reviews · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Review

473 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J A SuwaidiCenter for Coronary Physiology and Imaging, Division of Cardiovascular Diseases, and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
S Hamasaki
S T Higano
R A Nishimura
D R Holmes
A Lerman
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronary endothelial dysfunction is characterized by vasoconstrictive response to the endothelium-dependent vasodilator acetylcholine. Although endothelial dysfunction is considered an early phase of coronary atherosclerosis, there is a paucity of information regarding the outcome of these patients. Thus, this study was designed to evaluate the outcome of patients with mild coronary artery disease on the basis of their endothelial function. METHODS AND

resultsFollow-up was obtained in 157 patients with mildly diseased coronary arteries who had undergone coronary vascular reactivity evaluation by graded administration of intracoronary acetylcholine, adenosine, and nitroglycerin and intracoronary ultrasound at the time of diagnostic study. Patients were divided on the basis of their response to acetylcholine into 3 groups: group 1 (n=83), patients with normal endothelial function; group 2 (n=32), patients with mild endothelial dysfunction; and group 3 (n=42), patients with severe endothelial dysfunction. Over an average 28-month follow-up (range, 11 to 52 months), none of the patients from group 1 or 2 had cardiac events. However, 6 (14%) with severe endothelial dysfunction had 10 cardiac events (P<0.05 versus groups 1 and 2). Cardiac events included myocardial infarction, percutaneous or surgical coronary revascularization, and/or cardiac death.

conclusionsSevere endothelial dysfunction in the absence of obstructive coronary artery disease is associated with increased cardiac events. This study supports the concept that coronary endothelial dysfunction may play a role in the progression of coronary atherosclerosis.

Indexed as

AcetylcholineAdultAgedCerebrovascular CirculationCoronary DiseaseCoronary VesselsEndothelium, VascularFemaleFollow-Up StudiesHeart DiseasesHumansLongitudinal StudiesMaleMiddle AgedMyocardial InfarctionMyocardial RevascularizationAcetylcholine

Identifiers

PMID10704159
OpenAlexW2145899271

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 3 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.